Company Pacific Biosciences of California, Inc. Börse Stuttgart
Equities
P09
US69404D1081
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.186 EUR | +7.80% | -18.89% | -88.05% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Instrument
60.1
%
| 49 | 38.0 % | 120 | 60.1 % | +147.24% |
Consumable
31.6
%
| 60 | 46.7 % | 63 | 31.6 % | +5.74% |
Service and Other
8.3
%
| 20 | 15.3 % | 17 | 8.3 % | -15.08% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Americas
52.6
%
| 70 | 54.2 % | 105 | 52.6 % | +51.54% |
Asia-Pacific
27.2
%
| 36 | 28.2 % | 54 | 27.2 % | +50.65% |
Europe, Middle East, and Africa
20.3
%
| 23 | 17.6 % | 41 | 20.3 % | +79.92% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 14/00/14 |
Christian Henry
CEO | Chief Executive Officer | 56 | 01/18/01 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 28/20/28 |
Mark van Oene
COO | Chief Operating Officer | 51 | 08/21/08 |
Jonas Korlach
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/01 |
Kathy Ordoñez
BRD | Director/Board Member | 73 | 17/14/17 |
Todd Friedman
IRC | Investor Relations Contact | - | - |
Mike Goloubef
PRN | Corporate Officer/Principal | - | 01/20/01 |
Natalie Welch
HRO | Human Resources Officer | - | 01/08/01 |
Neil Ward
PRN | Corporate Officer/Principal | - | 08/21/08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 18/13/18 |
Marshall Mohr
BRD | Director/Board Member | 67 | 18/12/18 |
Christian Henry
CEO | Chief Executive Officer | 56 | 01/18/01 |
Director/Board Member | 70 | 01/09/01 | |
Lucy Shapiro
BRD | Director/Board Member | 83 | 12/12/12 |
Bill Ericson
BRD | Director/Board Member | 65 | 01/04/01 |
Kathy Ordoñez
BRD | Director/Board Member | 73 | 17/14/17 |
David Meline
BRD | Director/Board Member | 66 | 13/23/13 |
Hannah Valantine
BRD | Director/Board Member | 72 | 16/21/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 272,355,892 | 267,170,934 ( 98.10 %) | 0 | 98.10 % |
Company contact information
Pacific Biosciences of California, Inc.
1305 O'Brien Drive
94025, Menlo Park
+650 521 8000
http://www.pacb.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.59% | 204B | |
+3.92% | 178B | |
+30.07% | 156B | |
+32.42% | 113B | |
+2.32% | 64.26B | |
+19.65% | 54.98B | |
-1.86% | 47.44B | |
-9.53% | 36.7B | |
-1.28% | 34.84B |
- Stock Market
- Equities
- PACB Stock
- P09 Stock
- Company Pacific Biosciences of California, Inc.